Literature DB >> 11303757

Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4.

M Ingelson1, S F Fabre, L Lilius, C Andersen, M Viitanen, O Almkvist, L O Wahlund, L Lannfelt.   

Abstract

The tau gene has an important role in frontotemporal dementia (FTD) as pathogenic mutations have been found in hereditary forms of the disease. Furthermore, a certain extended tau haplotype has been shown to increase the risk for progressive supranuclear palsy, corticobasal degeneration, Parkinson's disease and, in interaction with the apolipoprotein E (apoE) epsilon4 allele, Alzheimer's disease. By microsatellite analysis we investigated an intronic tau polymorphism, in linkage disequilibrium with the extended tau haplotype, in FTD patients (n = 36) and healthy controls (n = 39). No association between any of the tau alleles/genotypes and FTD was seen, but certain tau alleles and apoE epsilon4 interactively increased the risk of FTD (p = 0.006). We thus propose that this extended tau haplotype in combination with apoE epsilon4 is a genetic risk factor for FTD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11303757     DOI: 10.1097/00001756-200104170-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males.

Authors:  R Srinivasan; Y Davidson; L Gibbons; A Payton; A M T Richardson; A Varma; C Julien; C Stopford; J Thompson; M A Horan; N Pendleton; S M Pickering-Brown; D Neary; J S Snowden; D M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

2.  Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology.

Authors:  Salvatore Oddo; Antonella Caccamo; David Cheng; Frank M LaFerla
Journal:  Brain Pathol       Date:  2008-07-24       Impact factor: 6.508

3.  Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation.

Authors:  Surendra S Ambegaokar; George R Jackson
Journal:  Hum Mol Genet       Date:  2011-09-23       Impact factor: 6.150

4.  Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.

Authors:  Wen-Hua Su; Zhi-Hong Shi; Shu-Ling Liu; Xiao-Dan Wang; Shuai Liu; Yong Ji
Journal:  Oncotarget       Date:  2017-07-04

5.  Plasma cholesterol in Alzheimer's disease and frontotemporal dementia.

Authors:  Pan Wang; Huihong Zhang; Yan Wang; Miao Zhang; Yuying Zhou
Journal:  Transl Neurosci       Date:  2020-05-18       Impact factor: 1.757

6.  Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland.

Authors:  Anna-Lotta Kaivorinne; Johanna Krüger; Katja Kuivaniemi; Hannu Tuominen; Virpi Moilanen; Kari Majamaa; Anne M Remes
Journal:  BMC Neurol       Date:  2008-12-17       Impact factor: 2.474

7.  Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort.

Authors:  Sheng Chih Jin; Pau Pastor; Breanna Cooper; Sebastian Cervantes; Bruno A Benitez; Cristina Razquin; Alison Goate; Carlos Cruchaga
Journal:  Alzheimers Res Ther       Date:  2012-08-20       Impact factor: 6.982

Review 8.  Tau protein in familial and sporadic diseases.

Authors:  Despina Yancopoulou; Maria Grazia Spillantini
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.